Abstract
In the search for mechanisms of obesity-mediated vascular pathology, attention has been focused on the role played by adipose tissue, a multifunctional organ involved not only in fat storage but also in the production of numerous hormones, growth factors, and cytokines with pleiotropic features. In the last decade the list of adipose-derived factors shown to be implicated either directly or indirectly in the regulation of vascular homeostasis through effects on blood pressure, inflammation, atherogenesis, coagulation, fibrinolysis, angiogenesis, proliferation, apoptosis, and immunity has increased at a phenomenal pace. By definition, adipocytokines are cytokines produced by adipocytes. Although adipose tissue secretes a wide variety of factors, strictly speaking, not all of them can be contemplated as cytokines. Interleukin-6, tumor necrosis factor-α, leptin, adipsin, resistin, adiponectin, and visfatin fall within the category that satisfies the stricter requirements to be properly classified as adipocytokines. However, the less strict term of adipokines has been coined to include a wider range of factors such as PAI-1, C-reactive protein, monocyte chemoattractant protein-1, serum amyloid A, and vascular endothelial growth factor, among others. Adipokines are known to contribute to the low-grade inflammation state observed in obese patients at the same time as participating in the development of obesity-related comorbidities, such as insulin resistance, metabolic syndrome, and atherogenesis. The molecular mechanisms linking the adiposity-inflammation-immunity cluster are complex. The triad of obesity-insulin resistance-cardiovascular disease is interwoven in a setting of inflammation, endothelial dysfunction and atherosclerosis in which adipokines act as markers of the acute phase reaction at the same time as being directly involved as causative factors in an extensive crosstalk between adipocytes and elements of the stroma vascular fraction. The current knowledge in this field is reviewed with a broad perspective approach.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eckel RH, Krauss RM. For the AHA Nutrition Committee. Circulation 1998;97:2099–2100.
Mokdad AH, Ford ES, Bowman BA, et al. JAMA 2003;289:76–79.
Gregg EW, Cheng YJ, Cadwell BL, et al. JAMA 2005;293:1868–1874.
Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, et al. Am J Physiol Endocrinol Metab 2001;280: E827–E847.
Marette A. Curr Opin Clin Nutr Metab Care 2002;5:377–383.
Blake GJ, Ridker PM. J Intern Med 2002;252:283–294.
Frühbeck G, Salvador J. Nutr Res 2004;24:803–826.
Frühbeck G. Curr Med Chem—Cardiovasc Hematol Agents 2004;2:197–208.
Hauner H. Physiol Behav 2004;83:653–658.
Granger JP. Am J Physiol Reg Integr Comp Physiol 2004;286:R989–R990.
Fantuzzi G. J Allergy Clin Immunol 2005;1 15:911–919.
Berg AH, Scherer PE. Circ Res 2005;96:939–949.
Gimeno RE, Klaman LD. Curr Opin Pharmacol 2005;5:122–128.
Juge-Aubry CE, Henrichot E, Meier CA. Best Pract Res Clin Endocrinol Metab 2005;19:547–566.
Kougias P, Chai H, Lin PH, et al. J Surg Res 2005;126:121–129.
Lau DCW, Dhillon B, Yan H, et al. Am J Physiol Heart Circ Physiol 2005;288:H2031–H2041.
Matsuzawa Y. Best Pract Res Clin Endocrinol Metab 2005;19:637–647.
Nawrocki AR, Scherer PE. Drug Discovery Today 2005;10:1219–1230.
Hutley L, Prins JB. Am J Med Sci 2005;330:280–289.
Trayhurn P. Acta Physiol Scand 2005;184:285–293.
Schäffler A, Schölmerich J, Büchler C. Nat Clin Pract Gastroenterol Hepatol 2005;2:103–111.
Yu Y-H, Ginsberg HN. Circ Res 2005;96:1042–1052.
Rudin E, Barzilai N. J Immunity Ageing 2005;2:1–3.
Matsuzawa Y. Nat Clin Pract Cardiovasc Med 2006;3:35–42.
Vague J. Am J Clin Nutr 1956;4:20–34.
Arner P. Biochem Soc Trans 2001;29 Part 2:72–75.
Fernández-Real JM, Ricart W. Endocrine Rev 2003;24:278–301.
Kaplanski G, Marin V, Montero-Julian F, et al. Trends Immunol 2003;24:25–29.
Chandrasekar B, Mitchell DH, Colston JT, et al. Circulation 1999;99:427–433.
Lyon CJ, Law RE, Hsueh WA. Endocrinology 2003;144:2195–2200.
Fried SK, Bunkin DA, Greenberg AS. J Clin Endocrinol Metab 1998;83:847–850.
Correia ML, Haynes WG. Curr Opin Nephrol Hypertens 2004;13:215–223.
Frühbeck G. Diabetes 1999;48:903–908.
Frühbeck G. Biochem J 2006;393:7–20.
Fortuño A, Rodríguez A, Gómez-Ambrosi J, et al. Endocrinology 2002;143:3555–3560.
Fantuzzi G, Faggioni R. J Leukoc Biol 2000;68:437–446.
La Cava A, Matarese G. Nat Rev Immunol 2004;4:371–379.
La Cava A, Alviggi C, Matarese G. J Mol Med 2004;82:4–11.
Maslowska M, Vu H, Phelis S, et al. Eur J Clin Invest 1999;29:679–686.
Steppan CM, Lazar MA. J Intern Med 2004;255:439–447.
Koerner A, Kratzsch J, Kiess W. Best Pract Res Clin Endocrinol Metab 2005;19:525–546.
Gómez-Ambrosi J, Frühbeck G. Ann Int Med 2001;135:306–307.
Lehrke M, Reilly MP, Millington SC, et al. PloS Medicine 2004;1:161–168.
Verma S, Li SH, Wang CH, et al. Circulation 2003;108:736–740.
Kawanami D, Maemura K, Takeda N, et al. Biochem Biophys Res Commun 2004;314:415–419.
Yamauchi T, Kamon J, Ito Y, et al. Nature 2003;423:762–769.
Kadowaki T, Yamauchi T. Endocrine Rev 2005;26:439–451.
Ouchi N, Kihara S, Arita Y, et al. Circulation 2000;102:1296–1301.
Xydakis AM, Case CC, Jones PH, et al. J Clin Endocrinol Metab 2004;89:2697–2703.
Pischon T, Girman CJ, Hotamisligil GS, et al. JAMA 2004;291:1730–1737.
Wellen KE, Hotamisligil GS. J Clin Invest 2003;1 12:1785–1788.
Fukuhara A, Matsuda M, Nishizawa M, et al. Science 2005;307:426–430.
Sethi JK, Vidal-Puig A. Trends Mol Med 2005;11:344–347.
Berndt J, Kloting N, Kralisch S, et al. Diabetes 2005;54:2911–2916.
Kralisch S, Klein J, Lossner U, et al. Am J Physiol Endocrinol Metab 2005;289:E586–E590.
Chen M-P, Chung F-M, Chang D-M, et al. J Clin Endocrinol Metab 2006;91:295–299.
Arner P. J Clin Endocrinol Metab 2006;91:28–30.
Skurk T, Havner H. Int J Obes Relat Metab Disord 2004;28:1357–1364.
Alessi MC, Peiretti F, Morange P, et al. Diabetes 1997;46:860–867.
Yudkin JS, Stehouwer CD, Emeis JJ, et al. Arterioscler Thromb Vasc Biol 1999;19:972–978.
Ouchi N, Kihara S, Nagai R, et al. Circulation 2003;107:671–674.
Verma S, Badiwala MV, Weisel RD, et al. J Thorac Cardiovasc Surg 2003;126:1886–1891.
Verma S, Kuliszewski MA, Li SH, et al. Circulation 2004;109:2058–2067.
Labarrere CA, Zaloga GP. Am J Med 2004;117:499–507.
Linton MF, Fazio S. Int J Obes Relat Metab Disord 2003;27(Suppl 3):S35–S40.
Charo IF, Taubman MB. Circ Res 2004;95:858–866.
Malavazos AE, Cereda E, Morricone L, et al. Eur J Endocrinol 2005;153:871–877.
Martinovic I, Abegunewardene N, Seul M, et al. Circ J 2005;69:1484–1489.
Clément K, Viguerie N, Poitou C, et al. FASEB J 2004;18:1657–1669.
Miyazawa-Hoshimoto S, Takahashi K, Bujo H, et al. Diabetologia 2003;46:1483–1488.
Gómez-Ambrosi J, Catalán V, Diez-Caballero A, et al. FASEB J 2004;18:215–218.
Verma S, Anderson TJ. Circulation 2002;105:546–549.
Libby P, Ridker PM, Maseri A. Circulation 2002;105:1135–1143.
Shoelson SE, Lee J, Yuan M. Int J Obes Relat Metab Disord 2003;27(Suppl 3):S49–S52.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Frühbeck, G. (2007). Vasoactive Factors and Inflammatory Mediators Produced in Adipose Tissue. In: Fantuzzi, G., Mazzone, T. (eds) Adipose Tissue and Adipokines in Health and Disease. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-59745-370-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-59745-370-7_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-721-1
Online ISBN: 978-1-59745-370-7
eBook Packages: MedicineMedicine (R0)